Regarding handling of outliers as per EMEA [Regulatives / Guidelines]

posted by keyurkakkad – 2011-01-27 10:54 (5632 d 08:00 ago) – Posting: # 6497
Views: 2,994

Dear All,

Please can anyone explain as per revised guideline of EMEA (European guidelines) how to handle outliers during pharmacokinetic and statistical analysis?

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
171 visitors (0 registered, 171 guests [including 24 identified bots]).
Forum time: 19:54 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5